SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-136949
Filing Date
2004-08-10
Accepted
2004-08-10 17:20:14
Documents
6
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004 d10q.htm 10-Q 386944
2 COLLABORATION AGREEMENT WITH CURAGEN CORPORATION, DATED JUNE 22, 2004 dex101.htm EX-10.1 188417
3 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 8524
4 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 8522
5 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3487
6 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3484
  Complete submission text file 0001193125-04-136949.txt   601703
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-50266 | Film No.: 04965209
SIC: 2836 Biological Products, (No Diagnostic Substances)